A new plasma biomarker clock offers an early glimpse into Alzheimer’s timing, potentially reshaping prevention research and therapeutic trials. Alzheimer’s disease (AD) is a progressive neurocognitive ...
A "clock" model based on a single blood test showed the ability to estimate when cognitively unimpaired individuals will likely develop Alzheimer's disease symptoms, researchers said. The model relies ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results